ADROEUR

Chinook Therapeutics, Inc.

A maker of precision medicines for rare, severe kidney diseases, Chinook Therapeutics develops targeted therapies for conditions like IgA nephropathy, using gene sequencing and human-derived organoids to hunt the root causes of disease. It was founded in 2019 through Versant Ventures' discovery lab in Vancouver and later merged with Aduro Biotech, adopting the Chinook name — a nod to the warm wind that sweeps its Seattle home and the Pacific Northwest.